Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?

A smart contact lens described in a research paper on Wednesday combines therapeutic and diagnostic capabilities for glaucoma ...

Last month, a group of 12 Senate Democrats proposed a framework for rebuilding the health care system. The idea was to spur ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.

Steve Ubl, chief executive of PhRMA, plans to step down at the end of the ‌year, after more than a decade leading the main ...

More data from the CDC: Overall, there were more than 3.6 million births in the U.S. last year. It sounds like a lot, but ...

We can’t afford another sweeping restructuring of the food supply based on imprecise interventions and uncertain science,” ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

MAHA ELEVATE could open a federal funding pipeline to interventions that can't survive contact with a plausibility filter.